Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 46

1.

Pathways to cognitive deficits in Down syndrome.

Sturgeon X, Le T, Ahmed MM, Gardiner KJ.

Prog Brain Res. 2012;197:73-100. doi: 10.1016/B978-0-444-54299-1.00005-4. Review.

PMID:
22541289
2.

Pharmacological approaches to improving cognitive function in Down syndrome: current status and considerations.

Gardiner KJ.

Drug Des Devel Ther. 2014 Dec 17;9:103-25. doi: 10.2147/DDDT.S51476. eCollection 2015. Review.

3.

Mouse models for Down syndrome-associated developmental cognitive disabilities.

Liu C, Belichenko PV, Zhang L, Fu D, Kleschevnikov AM, Baldini A, Antonarakis SE, Mobley WC, Yu YE.

Dev Neurosci. 2011;33(5):404-13. doi: 10.1159/000329422. Epub 2011 Aug 25. Review.

4.

Mouse models of Down syndrome as a tool to unravel the causes of mental disabilities.

Rueda N, Flórez J, Martínez-Cué C.

Neural Plast. 2012;2012:584071. doi: 10.1155/2012/584071. Epub 2012 May 22. Review.

5.

Gene therapy for Down syndrome.

Fillat C, Altafaj X.

Prog Brain Res. 2012;197:237-47. doi: 10.1016/B978-0-444-54299-1.00012-1. Review.

PMID:
22541296
6.

Is it possible to improve neurodevelopmental abnormalities in Down syndrome?

Bartesaghi R, Guidi S, Ciani E.

Rev Neurosci. 2011;22(4):419-55. doi: 10.1515/RNS.2011.037. Review.

PMID:
21819263
7.
8.

Trisomy 21 and Down syndrome: a short review.

Sommer C, Henrique-Silva F.

Braz J Biol. 2008 May;68(2):447-52. Review.

9.

Molecular basis of pharmacotherapies for cognition in Down syndrome.

Gardiner KJ.

Trends Pharmacol Sci. 2010 Feb;31(2):66-73. doi: 10.1016/j.tips.2009.10.010. Epub 2009 Dec 4. Review.

10.

Cognitive Impairment, Neuroimaging, and Alzheimer Neuropathology in Mouse Models of Down Syndrome.

Hamlett ED, Boger HA, Ledreux A, Kelley CM, Mufson EJ, Falangola MF, Guilfoyle DN, Nixon RA, Patterson D, Duval N, Granholm AC.

Curr Alzheimer Res. 2016;13(1):35-52. Review.

11.

Mouse models of cognitive disorders in trisomy 21: a review.

Sérégaza Z, Roubertoux PL, Jamon M, Soumireu-Mourat B.

Behav Genet. 2006 May;36(3):387-404. Epub 2006 Mar 8. Review.

PMID:
16523244
12.

Human and mouse model cognitive phenotypes in Down syndrome: implications for assessment.

Edgin JO, Mason GM, Spanò G, Fernández A, Nadel L.

Prog Brain Res. 2012;197:123-51. doi: 10.1016/B978-0-444-54299-1.00007-8. Review.

PMID:
22541291
13.

Aging and intellectual disability: insights from mouse models of Down syndrome.

Ruparelia A, Pearn ML, Mobley WC.

Dev Disabil Res Rev. 2013;18(1):43-50. doi: 10.1002/ddrr.1127. Review.

PMID:
23949828
14.

Using mouse models to explore genotype-phenotype relationship in Down syndrome.

Salehi A, Faizi M, Belichenko PV, Mobley WC.

Ment Retard Dev Disabil Res Rev. 2007;13(3):207-14. Review.

PMID:
17910089
15.

From abnormal hippocampal synaptic plasticity in down syndrome mouse models to cognitive disability in down syndrome.

Cramer N, Galdzicki Z.

Neural Plast. 2012;2012:101542. doi: 10.1155/2012/101542. Epub 2012 Jul 12. Review.

16.

Epigenetics: the neglected key to minimize learning and memory deficits in Down syndrome.

Dekker AD, De Deyn PP, Rots MG.

Neurosci Biobehav Rev. 2014 Sep;45:72-84. doi: 10.1016/j.neubiorev.2014.05.004. Epub 2014 May 21. Review.

PMID:
24858130
17.

Down syndrome--recent progress and future prospects.

Wiseman FK, Alford KA, Tybulewicz VL, Fisher EM.

Hum Mol Genet. 2009 Apr 15;18(R1):R75-83. doi: 10.1093/hmg/ddp010. Review.

18.

Murine models for Down syndrome.

Dierssen M, Fillat C, Crnic L, Arbonés M, Flórez J, Estivill X.

Physiol Behav. 2001 Aug;73(5):859-71. Review.

PMID:
11566219
19.

Mouse models of Down syndrome: gene content and consequences.

Gupta M, Dhanasekaran AR, Gardiner KJ.

Mamm Genome. 2016 Dec;27(11-12):538-555. Epub 2016 Aug 18. Review.

PMID:
27538963
20.

Molecular genetic analysis of Down syndrome.

Patterson D.

Hum Genet. 2009 Jul;126(1):195-214. doi: 10.1007/s00439-009-0696-8. Epub 2009 Jun 13. Review.

PMID:
19526251

Supplemental Content

Support Center